Sarepta Therapeutics (SRPT)

$68.47 0. (0.00%)
16:00 EDT SRPT Stock Quote Delayed 30 Minutes

7 Potential Biotech Stocks Buyout Targets in 2022

Big biopharma companies usually rely on M&A to get immediate access to a new class of drug or technology, fill in the gap in their pipeline and compensate for revenue loss from patent expiration of blockbuster products.

Positive Spin Isn’t Working for Sarepta Therapeutics

SRPT Stock Alert: Why Sarepta Therapeutics Stock Is Plunging Today

Sarepta Therapeutics News: SRPT Stock Skyrockets 36% on FDA Approval of Muscular Dystrophy Drug

More Articles
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 5.99B
PE Ratio -24.28
EPS -2.82
Volume (Avg. Vol.)
Day's Range -
52-Week Range $61.28 - $101.24
Dividend & Yield N/A (N/A)